Comparison of Two Dementia Care Interventions and Usual Care on Days Spent at Home: The D‐ CARE Randomized Clinical Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: BACKGROUND: Days spent at home (DSAH) is a clinically meaningful patient-centered outcome among persons living with dementia (PLWD). OBJECTIVE: To evaluate whether either of two dementia care interventions increased the number of DSAH compared with each other and with usual care. DESIGN: Pragmatic 18-month 3-arm randomized clinical trial conducted from June 2019 through August 2023. SETTING: Four clinical trial sites in North Carolina, Texas, and Pennsylvania. PARTICIPANTS: Total of 1968 (90.4% of 2176) community-living PLWD with complete Medicare data. INTERVENTIONS: Health-system dementia care (HSDC) co-management by advance practice providers, community-based dementia care (CBDC) provided telephonically by a social worker, nurse, or licensed therapist, and usual care (UC), each lasting up to 18 months. MAIN OUTCOME: The number of DSAH was calculated as 546 (i.e., 18 months) minus the number of overnight days in a health care facility and days not alive, using data from Medicare. RESULTS: The percentages of DSAH were 83.5, 84.9, and 83.6 for the HSDC, CBDC, and UC groups, respectively. For each pairwise comparison among the three groups, incidence rate ratios for DSAH approximated 1.0, denoting no differences, and the corresponding mean differences in DSAH were small and not statistically significant: -7.2 (98.3% CI: -31.4 to 17.0) for HSDC versus CBDC; -0.3 (-48.4 to 47.7) for HSDC versus UC; and 6.9 (-41.3 to 55.5) for CBDC versus UC. There were no substantive differences in mean values across the three groups for days in any of the health care facilities. Mean [SD] days not alive were greatest for UC (68.3 [134.4]), followed by HSDC (65.3 [133.3]) and CBDC (60.0 [129.8]). CONCLUSIONS: In this pragmatic randomized clinical trial of dementia care programs, health system-based and community-based interventions did not differ from each other or from usual care in the number of DSAH for PLWD over the 18-month intervention period. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT03786471.
DOI: 10.1111/jgs.70838
Institutions: Yale University, University of California, Los Angeles, University of Southern California, Baylor Scott & White Health, Atrium Health Wake Forest Baptist, Wake Forest University Health Sciences, Wake Forest University, The University of Texas Medical Branch at Galveston, The University of Texas at San Antonio, OU Health, University of Oklahoma Health Sciences Center
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,760
Awards: Wake Forest Alzheimer's Disease Core Center, Pragmatic Trial of the Effectiveness and Cost-Effectiveness of Dementia Care, Yale University Clinical and Translational Science Award Program, UTMB Claude D. Pepper Older Americans Independence Center, The Mexican Health Aging Study (MHAS), San Antonio Claude D. Pepper Older Americans Independence Center, Claude D. Pepper Older Americans Independence Center at Yale
OpenAlex ID: W7236236853
